Exubera, the new inhaled insulin

Patients will soon be trying Exubera, the new inhaled insulin.

Exubera is an alternative to short-acting or regular insulin... for patients with either type 1 or type 2 diabetes.

It has a fast onset...for use up to 10 minutes before meals.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote